Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis

REFERENCES

• Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: sec-ond revision, Edomonton, 2001. J Rheumatol. 2004;31:390–2.
   Google Scholar
• De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A. Correlation of serum interleukin 6 levels with joint involvement and thrombocytosis in systemic juvenile idiopathic arthritis. Arthritis Rheum. 1991;34:1158–63.
   PubMed Web of Science ®Google Scholar
• Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W, et al. Serum cytokines in juvenile rheumatoid arthritis (JRA). Correlation with conventional inflammatory parameters and clinical subtypes. Arthritis Rheum. 1995;38: 211–20.
   Google Scholar
• Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacy of etanercept for the treatment of juvenile idio-pathic arthritis according to the onset type. Arthritis Rheum. 2003;48:1093–101.
   PubMed Web of Science ®Google Scholar
• Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biol-ogics for the treatment of juvenile idiopathic arthritis: a system-atic review and critical analysis of the evidence. Clin Rheumatol. 2008;27:67–76.
   Google Scholar
• Woo P, Wilkinson N, Prieur AM, Southwood T, Leone V, Livemore P, et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther. 2005;7: R1281–8.
   PubMed Web of Science ®Google Scholar
• Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M, et al. Therapeutic Efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:818–25.
   PubMed Web of Science ®Google Scholar
• Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371: 998–1006.
   PubMed Web of Science ®Google Scholar
• Ilowite N, Ponas 0, Reiff A, Rudge S, Punaro M, Martin A, et al. Anakinra in the treatment of polyarticular-course juvenile rheu-matoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol. 2009;28: 129–37.
   Google Scholar
• Ruperto N, Quartier P, Wulffraat N, Woo P, Ravelli A, Mouy R, et al. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum. 2012;64:557–67.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Ruperto N, Gerloni V, Simonini G, Cortis E, Lepore L, et al. Preliminary evidence that etanercept may reduce radio-graphic progression in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2008;26:688–92.
   PubMed Web of Science ®Google Scholar
• Tse SML, Laxer RM, Babyn PS, Doria AS. Radiologic improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-a blockade with e-tanercept. J Rheumatol. 2006;33:1186–8.
   PubMed Web of Science ®Google Scholar
• Inaba Y, Ozawa R, Imagawa T, Mori M, Hara Y, Miyamae T, et al. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment. Ann Rheum Dis. 2011;70:1693–5.
   PubMed Web of Science ®Google Scholar
• Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202–9.
   PubMed Web of Science ®Google Scholar
• Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37:1761–9.
   PubMed Web of Science ®Google Scholar
• Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol. 1995;22: 1974–5.
   PubMed Web of Science ®Google Scholar
• Poznanski AK, Hernandez RJ, Guire KE, Bereza UL, Gam SM. Carpal length in children: a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syn-dromes. Radiology. 1978;129:661–8.
   Google Scholar
• Inamo Y, Harada K. Normal range of carpal length in Japanese children. Nihon Univ J Med. 1998;40:81–7.
   Google Scholar
• Strand V, Cohen S, Schiff M, Weaver A, Fleischmann RM, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med. 1999;159:2542–50.
   PubMed Web of Science ®Google Scholar
• Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clini-cal outcomes. Arthritis Rheum. 2002;46:1443–50.
   PubMed Web of Science ®Google Scholar
• Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of eta-nercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial. Lancet. 2004;363:675–81.
   PubMed Web of Science ®Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breed-veld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000;343: 1594–602.
   Google Scholar
• Harel L, Wagner-weiner L, Poznanski AK, Spencer CH, Ekwo E, Magilavy DB. Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Arthritis Rheum. 1993;36: 1370–4.
   PubMed Web of Science ®Google Scholar
• Ravelli A, Ioseliani M, Norambuena X, Sato J, Pistorio A, Rossi F, et al. Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum. 2007;56:3087–95.
   PubMed Web of Science ®Google Scholar
• Poznanski AK, Conway JJ, Shkolink A, Pachman LM. Radio-logical approaches in the evaluation of joint disease in children. Rheum Dis Clin N Am. 1987;13:57–73.
   PubMed Web of Science ®Google Scholar
• Rossi F, Dia FD, Galipo 0, Pistorio A, Valle M, Magni-manzoni S, et al. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum. 2006;55:717–23.
   Google Scholar
• Pettersson H, Rydholm U. Radiologic classification of knee joint destruction in juvenile chronic arthritis. Pediatr Radiol. 1984;14: 419–21.
   PubMed Web of Science ®Google Scholar
• Rau R, Wassenberg S, Herbom G, Perschel WT, Freitag G. Identification of radiologic healing phenomenon in patients with rheumatoid arthritis. J Rheumatol. 2001;28:2608–15.
   Google Scholar
• Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of oste-oporosis. N Engl J Med. 1995;332:305–11.
   PubMed Web of Science ®Google Scholar
• Theoleyre S, Wittant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPGRANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004;15:457–75.
   PubMed Web of Science ®Google Scholar
• Kato A, Matsuo S, Takai H, Uchiyama Y, Mihara M, Suzuki M. Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model. Exp Mol Pathol. 2008;84:262–70.
   PubMed Web of Science ®Google Scholar
• Seki E, Matsushita I, Sugiyama E, Taki H, Shinoda K, Hounoki H, et al. Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies. Clin Rheumatol. 2009;28:453–60.
   PubMed Web of Science ®Google Scholar
• Levinson JE, Wallace CA. Dismantling the pyramid. J Rheumatol Suppl. 1992;33:6–10.
   PubMedGoogle Scholar
• Magni-manzoni S, Rossi F, Pistorio A, Temporini F, Viola S, Beluffi G, et al. Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. Arthritis Rheum. 2003;48:3509–17.
   Google Scholar